Abstract

Doc number: 86

Abstract

Background: To show effectiveness of low-dose splenic irradiation in symptomatic congestive splenomegaly.

Methods: Five patients were referred to our department for symptomatic congestive splenomegaly within three years. Primary diseases were autoimmune hepatitis with liver cirrhosis (n = 2), cystic fibrosis (n = 1), granulomatous liver disease (n = 1) and Werlhof disease with liver cirrhosis (n = 1). Mean age was 54 years (range: 36-67). Patients received splenic irradiation with a total dose of 3 Gy (single dose: 0.5 Gy). One patient was re-irradiated after long-term failure with the same treatment schedule.

Results: In four patients long term relief of splenic pain could be observed during the follow-up time of median 20 (range: 2-36) months. Four patients showed haematological response after irradiation with an increase of erythrocytes, leucocytes and/or platelets. A slightly decrease in spleen size was found in two patients.

Conclusions: Low-dose splenic irradiation in symptomatic congestive splenomegaly is feasible and perhaps as effective as in lympho-and myeloproliferative malignancies regarding pain relief and haematological response.

Details

Title
Low-dose splenic irradiation in symptomatic congestive splenomegaly: report of five cases with literature data
Author
Bruns, Frank; Bremer, Michael; Dettmer, Arne; Janssen, Stefan
Pages
86
Publication year
2014
Publication date
2014
Publisher
BioMed Central
e-ISSN
1748-717X
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
1514014751
Copyright
© 2014 Bruns et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.